ARMR Launches up to $30M Capital Raise to Advance Biodefense Platform Against Fentanyl and AI-Driven Synthetic Drug Threats

ARMR is developing pre-exposure biodefense solutions to protect American lives from fentanyl and synthetic drug threats weaponized by U.S. adversaries. Up to $30 million private placement offering enables qualified investors to gain access ahead of an expected public offering and exchange...

Read More